Quotient (QTNT) Reports Q3 Loss of $0.48
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq rallies as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
- After-Hours Movers: WDC, BE, DECK, FIX, RNG
UBS Reiterates Buy as Quotient (QTNT) Believes Bulk of MosaiQ Development Risk is Complete
February 9, 2016 9:16 AM ESTUBS maintained a Buy rating on Quotient (NASDAQ: QTNT), and cut the price target to $25.00 (from $26.00), following the company's 3Q earnings report. F3Q16 featured meaningful progress, execution, and updates to the MosaiQ. Management reiterated plans on the earnings call to enter field trials in the US and EU. Management believes the bulk of the development risk for MosaiQ is... More
Quotient (QTNT) 4.4M Offering Prices at $9/Share
February 5, 2016 7:36 AM ESTQuotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, announced the pricing of an underwritten public offering of 4,444,445 of its ordinary shares at a price to the public of $9.00 per share. The net proceeds to Quotient from this offering are expected to be $36.9 million, after deducting... More



